ACE and cardiomyopathy: The current standard of care recommended by the DMD Care Considerations Working Group to delay the onset of cardiomyopathy includes the use of angiotensin-converting enzyme (ACE) inhibitors (i.e., Perindopril) by 10 years of age [2].